Company intelligence
Fresenius Kabi
About Fresenius Kabi
As a global healthcare company, Fresenius Kabi is Committed to Life. The company’s products, technologies, and services are used for the therapy and care of critically and chronically ill patients. With over 41,000 employees and present in over 100 countries, Fresenius Kabi’s expansive product portfolio focuses on providing access to high-quality and lifesaving medicines and technologies. In Biopharma, Fresenius Kabi offers cutting-edge biosimilars for autoimmune diseases and oncology. With leading market positions in Medical Nutrition, a broad portfolio of enteral and parenteral products makes a distinct difference in patients’ nutritional status. In MedTech, the company provides vital infusion pumps, cell and gene therapy devices, disposables, and more. Fresenius Kabi is the global leader in supplying blood collection bags and devices, supporting blood banks and healthcare facilities worldwide. The company’s I.V. Generics and Fluids for infusion therapy help save millions of lives every year, in emergency medicine, surgery, oncology, and intensive care. Fresenius Kabi takes a holistic approach to healthcare and uniquely combines experience, expertise, innovation, and dedication – making a difference in the lives of 450 million patients annually. With the #FutureFresenius strategy, the company is developing, producing, and selling new products and technologies and aspires to expand its position as a leading global provider of therapies, improve patient care, generate sustainable value for stakeholders – shaping the future of healthcare. Fresenius Kabi is an operating company of the Fresenius Group, founded in 1912, along with Helios and Quirónsalud. As ONE team, the companies in the Fresenius Group are committed to providing lifesaving and life-changing healthcare solutions on a global scale. User information & community guidelines: https://www.fresenius-kabi.com/social-media-terms-conditions Imprint: www.fresenius-kabi.com/imprint
Verified activity
Signals from Fresenius Kabi
19 published signals
Presence & Recognition
Fresenius Kabi welcomed visitors to its booth at ESPEN 2026 in Berlin.
Reported by Fresenius Kabi
People
Fresenius Kabi introduced a new European commercial development team for cell therapies with two new team members joining over the summer.
Reported by Lindsey Clarke
Presence & Recognition
Fresenius Kabi participated in the ESPEN 26 event in Berlin, Germany, focusing on Medical Nutrition and Metabolism.
Reported by Anne de Warren
Presence & Recognition
Fresenius Kabi participated in the Dreamforce 2026 conference on stage with Tara Helm and Megan Frost from Salesforce and Mary Treacy from Novartis to discuss the Agentic Pharma Playbook session on AI for the entire value chain.
Reported by Kai Dins
Presence & Recognition
Fresenius Kabi alumni representatives attended the Jumpstart Alumni Berlin 2026 event.
Reported by Dr. Anke Wenn
Presence & Recognition
Fresenius Kabi hosted an event on Thursday, September 10th, 2026, featuring sustainability professionals discussing Claude cowork for sustainability work.
Reported by Zyad Hatquai
Products & Services
Fresenius Kabi developed NutriChef, a food tube feed made with ingredients derived from fruits, vegetables, legumes, grains, herbs, and spices, inspired by familiar foods and everyday meals.
Reported by Fresenius Kabi
Products & Services
Fresenius Kabi launched its first real food ingredients tube feed called Nutrichef as part of the Fresenius Medical Nutrition Business Unit.
Reported by Sebastien Guery
Presence & Recognition
Fresenius Kabi is exhibiting at the ESPEN 2026 satellite symposium in Berlin at the Estrel Congress Center, with live stream available.
Reported by Fresenius Kabi
Presence & Recognition
Fresenius Kabi is hosting a roundtable tomorrow at WIAT exploring why successful teams do not happen by accident.
Reported by Lindsey Clarke
Presence & Recognition
Fresenius Kabi employee Brian Weigand is attending Cell & Gene Therapy International in Boston this September.
Reported by Brian Weigand
Research & Knowledge
Fresenius Kabi published an article by Anthropic titled The AI Native SDLC Playbook, focusing on the build stage of AI content delivery.
Reported by Zyad Hatquai
Presence & Recognition
Fresenius Kabi is hosting an ICRNM 2026 lunch symposium titled Nutrition-Centered Management along the Patient Journey: Optimizing Chronic Kidney Disease Outcomes on September 18, 2026 at the Estrel Congress Center in Berlin.
Reported by Fresenius Kabi
Presence & Recognition
Fresenius Kabi will attend the Advanced Therapies Europe, Immune RESET 2026, and 33rd ESGCT Annual Congress in Barcelona, Magdeburg, and Hamburg respectively.
Reported by Fresenius Kabi
Presence & Recognition
Fresenius Kabi is hosting the Women in Venture Capital event on November 3 at NCBiotech for a conversation with women working at the intersection of science, entrepreneurship, and investment.
Reported by Shannon Speer, PhD, MBA
Presence & Recognition
Fresenius Kabi is hosting the Women as Founders event on September 10 at SAS for a conversation with women who have built, invested in, and supported companies across the life sciences ecosystem.
Reported by Shannon Speer, PhD, MBA
Presence & Recognition
Fresenius Kabi is hosting WIB-RTP Group Dinners for smaller group dinners designed to make it easier to have deeper conversations and get to know other WIB members.
Reported by Shannon Speer, PhD, MBA
Presence & Recognition
Fresenius Kabi hosted an event on Thursday, September 10th, 2026, featuring a talk on building 3000 sustainability deliverables, Claude chat, cowork, and code.
Reported by Zyad Hatquai
Presence & Recognition
Fresenius Kabi hosted its first ONE HR Switzerland Offsite following the launch of Functional Excellence in Switzerland, featuring Swiss HR team engagement and collaboration.
Reported by Svenja Reith